Tony S. K. Mok, Helena Alexandra Yu, Sun Min Lim, Isamu Okamoto, Maurice Pérol, Silvia Novello, Christophe Alfons Dooms, Jong-Mu Sun, Steven Chuan-Hao Kao, Pasi A. Jänne, Martin Reck, Conor Ernst Steuer, Makoto Nishio, Yi-Long Lung Cancer Wu, Xiaofang Li, Ronan Fougeray, Ragini Kudchadkar, Jianyu Wu, Stephen Esker, Antonio Passaro. "Patritumab deruxtecan (HER3-DXd) in resistant
            <i>EGFR</i>
            -mutated (
            <i>EGFR</i>
            m) advanced non-small cell lung cancer (NSCLC) after a third-generation EGFR TKI: The phase 3 HERTHENA-Lung02 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8506